Phio Pharmaceuticals Corp.
IMMUNOTHERAPY OF CANCER

Abstract:

Immunogenic modulators and compositions comprising oligonucleotide agents capable of inhibiting suppression of immune response by reducing expression of one or more gene involved with an immune response suppression mechanism.